Publications

Search

Show only items where

Author

Type

Term

Year

Keyword

Found 125 results

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

N

Hu Y, Liu L, Lu B, Zhu D, Ribeiro R, Diniz B, Thomas PB, Ahuja AK, Hinton DR, Tai Y-C et al.. 2012. A novel approach for subretinal implantation of ultrathin substrates containing stem cell-derived retinal pigment epithelium monolayer. Ophthalmic Research. 48(4):186-91.

Clegg DO. 2000. Novel roles for integrins in the nervous system. Molecular Cell Biology Research Communications. 3:1–7.

O

Kashani AH, Lebkowski JS, Rahhal FM, Avery RL, Salehi-Had H, Chen S, Chan C, Palejwala N, Ingram A, Dang W et al.. 2021. One-Year Follow-Up in a Phase 1/2a Clinical Trial of an Allogeneic RPE Cell Bioengineered Implant for Advanced Dry Age-Related Macular Degeneration.. Transl Vis Sci Technol. 10(10):13.

Hikita S, Clegg DO. 2004. Osteopontin is Expressed in Developing Mouse Optic Tract and Supports Axon Extension of Retinal Ganglion Cells. Investigative Ophtalmology & Visual Science. 45:5371.

Hikita S, Clegg DO. 2002. Osteopontin is Expressed in Developing Mouse Retina and Supports Integrin-Dependent Neurite Outgrowth. Investigative Ophtalmology & Visual Science. 43:2698.

Hikita ST, Vistica BP, Jones HR, Keswani JR, Watson MM, Ericson VR, Ayoub GS, Gery I, Clegg DO. 2006. Osteopontin is proinflammatory in experimental autoimmune uveitis. Investigative Ophthalmology & Visual Science. 47(10):4435-43.

P

Foltz LP, Clegg DO. 2018. Patient-derived induced pluripotent stem cells for modelling genetic retinal dystrophies.. Progress in Retinal and Eye Research.

Rowland TJ, Buchholz DE, Clegg DO. 2012. Pluripotent human stem cells for the treatment of retinal disease. Journal of Cellular Physiology. 227(2):457-66.

Pennington BO, Clegg DO. 2016. Pluripotent Stem Cell-Based Therapies in Combination with Substrate for the Treatment of Age-Related Macular Degeneration. Journal of Ocular Pharmacology & Therapeutics.

Gupta N, Vestberg R, Malkoch M, Hikita S, Thibault R, Lingwood M, McCarney E, Han S-I, Clegg D, Hawker CJ. 2006. POLY 415-Characterization of poly (ethylene glycol) hydrogels formed via Click chemistry. Abstracts of Papers of the American Chemincal Society. 232

Carr A-J, Vugler AA, Hikita ST, Lawrence JM, Gias C, Chen LLi, Buchholz DE, Ahmado A, Semo M'ayan, Smart MJK et al.. 2009. Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat. PLoS One. 4(12):e8152.

R

Pennington BOcean, Buchholz DE, Hinman C, Croze R, Coffey PJ, Clegg DO. 2013. Rapid and efficient derivation of retinal pigment epithelium (RPE) from human pluripotent stem cells. FASEB Journal. 27

Buchholz DE, Pennington BO, Croze RH, Hinman CR, Coffey PJ, Clegg DO. 2013. Rapid and efficient directed differentiation of human pluripotent stem cells into retinal pigmented epithelium. Stem Cells Translational Medicine. 2(5):384-93.

Foltz LP, Clegg DO. 2017. Rapid, Directed Differentiation of Retinal Pigment Epithelial Cells from Human Embryonic or Induced Pluripotent Stem Cells. J Vis Exp. (128)

Lin H, Clegg DO, Lal R. 1998. Real time proteolysis of single collagen I molecules imaged with an atomic force microscope. Molecular Biology of the Cell. 9:58A–58A.

Clegg DO. 2016. Regenerating Perfection. J Ocul Pharmacol Ther. 32(5):237.

Clegg DO, Large TH, Bodary SC, Reichardt LF. 1989. Regulation of nerve growth factor mRNA levels in developing rat heart ventricle is not altered by sympathectomy. Developmental Biology. 134(1):30-7.

Hu Q, Chen R, Teesalu T, Ruoslahti E, Clegg DO. 2014. Reprogramming human retinal pigmented epithelial cells to neurons using recombinant proteins. Stem Cells Translational Medicine. 3(12):1526-34.

Sowden J, Beebe D, Powell C, Bird A, Cepko C, Clegg DO, Gamm DA, Goldman D, Hitchcock P, Hyde D et al.. 2014. Restoring Vision to the Blind: The Lasker/IRRF Initiative for Innovation in Vision Science.. Transl Vis Sci Technol. 3(7):1.

Clegg DO, Buchholz D, Hikita S, Rowland T, Hu Q, Johnson LV. 2008. Retinal pigment epithelial cells: development in vivo and derivation from human embryonic stem cells in vitro for treatment of age-related macular degeneration. Stem Cell Research and Therapeutics. :1–24.

Croze RH, Buchholz DE, Radeke MJ, Thi WJ, Hu Q, Coffey PJ, Clegg DO. 2014. ROCK Inhibition Extends Passage of Pluripotent Stem Cell-Derived Retinal Pigmented Epithelium. Stem Cells Translational Medicine. 3(9):1066-78.

Croze RH, Thi WJ, Clegg DO. 2016. ROCK Inhibition Promotes Attachment, Proliferation, and Wound Closure in Human Embryonic Stem Cell-Derived Retinal Pigmented Epithelium. Transl Vis Sci Technol. 5(6):7.

Clegg DO, Koshland DE. 1984. The role of a signaling protein in bacterial sensing: behavioral effects of increased gene expression. Proceedings of the National Academy of Sciences. 81(16):5056-60.

Clegg DO, Cann GM, Bradshaw AD, Gervin DB, Hunter AW. 1996. Role of beta1 integrins in retinal development. Investigative Ophthalmology & Visual Science. 37:3168–3168.

Rowland TJ, Miller LM, Blaschke AJ, E Doss L, Bonham AJ, Hikita ST, Johnson LV, Clegg DO. 2010. Roles of integrins in human induced pluripotent stem cell growth on Matrigel and vitronectin. Stem Cells & Development. 19(8):1231-40.

Pages